Here's Why You Should Retain Edward Lifesciences (EW) Stock Now

Edwards Lifesciences Corporation (EW) is likely to grow in the coming quarters, backed by the strong prospects of the Critical Care business, one of the rapidly growing businesses of the company. The RESILIA portfolio continues to gain significant traction with widespread adoption. Within TMTT (Transcatheter Mitral and Tricuspid Therapies), new therapy introductions, clinical trial achievements and geographic expansion look promising for the company.Meanwhile, elevated expenses and foreign exchange headwind ...